Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinoma
Date
2021-06
Authors
Language
American English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
AACR
Abstract
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Armstrong, A. J., Nixon, A. B., Carmack, A., Yang, Q., Eisen, T., Stadler, W. M., Jones, R. J., Garcia, J. A., Vaishampayan, U. N., Picus, J., Hawkins, R. E., Hainsworth, J. D., Kollmannsberger, C. K., Logan, T. F., Puzanov, I., Pickering, L. M., Ryan, C. W., Protheroe, A., George, D. J., & Halabi, S. (2021). Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinoma. Clinical Cancer Research, 27(12), 3503–3503. https://doi.org/10.1158/1078-0432.CCR-21-1636
ISSN
1078-0432, 1557-3265
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Clinical Cancer Research
Rights
Publisher Policy
Source
Author
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Author's manuscript